Evaluation of Knowledge Among Adolescents With Sickle Cell Disease. (SEXODREP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03235011|
Recruitment Status : Completed
First Posted : August 1, 2017
Last Update Posted : February 6, 2019
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease|
|Sickle Cell Disease|
Sickle cell teenagers receive regular hospital medical care.
Adolescence is the time when the pathophysiology of the disease is re-explained and when questions around puberty (possibly delayed), sexuality and contraception are discussed.
Sickle cell disease, like any chronic disease, can have repercussion on the development and behavior of young patients.
Knowledge and understanding of young patients with sickle cell disease around these issues may be insufficient.
|Study Type :||Observational|
|Actual Enrollment :||99 participants|
|Official Title:||Evaluation of Knowledge and Practices About Contraception, Sexuality and Transmission Among Adolescents With Sickle Cell Disease.|
|Actual Study Start Date :||March 10, 2017|
|Actual Primary Completion Date :||January 31, 2018|
|Actual Study Completion Date :||January 31, 2018|
- Score value of the questionnaire on general knowledge on contraception [ Time Frame: at inclusion ]questionnaire on general knowledge on contraception rated by 4 questions
- Score value of the questionnaire on specific knowledge on the transmission of the disease [ Time Frame: at inclusion ]
- Score value of the questionnaire on the transmission of the disease knowledge [ Time Frame: at inclusion ]
- Score value of the questionnaire on specific knowledge about the impact of sickle cell disease on the course of puberty [ Time Frame: at inclusion ]
- Score value of the questionnaire onspecific knowledge about the impact of sickle cell disease on the course of sexuality [ Time Frame: at inclusion ]
- age of the patient with sickle cell disease [ Time Frame: at inclusion ]
- gender of the patient with sickle cell disease [ Time Frame: at inclusion ]
- number of hospitalizations of the patient with sickle cell disease [ Time Frame: at inclusion ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||14 Years to 19 Years (Child, Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Probability Sample|
- Patients with sickle cell disease followed at the CHIC
- Aged 14 to 19
- Both sexes
- Neurological disorders that can impede understanding of the questionnaire.
- Refusal to participate.
- Not affiliated to social security.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03235011
|Centre Hospitalier Intercommunal de Créteil|
|Créteil, Creteil, France, 77500|
|Responsible Party:||Adele CARLIER-GONOD, Peadiatrician, Centre Hospitalier Intercommunal Creteil|
|Other Study ID Numbers:||
|First Posted:||August 1, 2017 Key Record Dates|
|Last Update Posted:||February 6, 2019|
|Last Verified:||February 2019|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
Anemia, Sickle Cell
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn